Insights

  • Date

  • Content Type

  • Reset

Blog

What a year! Biopharma Excellence has been easing the path to market for a whole host of advanced therapies and biosimilars

28.11.22
by Dr. Christian K Schneider Head of Biopharma Excellence   As Biopharma Excellence marks its

Blog

The big gene edit: the view from the front line

9.11.22

By Tim Farries, PhD

Reflections on a lively panel debate at the 2022 Cell & Gene Meeting on the

Blog

Bringing vaccine equity to Africa through ‘tech and reg’ transfer

8.11.22
Michael Pfleiderer, Ph.D., Principal Consultant and Senior Director Efforts to address Covid-19 worldwide through vaccination

Blog

How our vaccines team supports innovation across global healthcare systems

8.11.22

By Michael Pfleiderer, PhD

Development of vaccines is a complex, evolving and highly specialized field that spans innovation, regulatory

Blog

Navigating the complex and evolving regulatory environment of 3D Printing

20.09.22

By Elena Meurer

Interest in manufacturing solutions that utilize 3D printing technology is constantly growing. Recently, 3D printing

Blog

On the acceleration of gene editing: what’s next?

20.09.22

By Tim Farries, PhD

A timely panel debate is coming, and Biopharma Excellence will be privileged to moderate it,